Clinical and biochemical indicators of disease severity and neurological findings in COVID-19: A study of King Edward Medical University (KEMU), Pakistan.

Iftikhar, Sadaf; Ghias, Mamoona; Shahid, Saman; Ali, Muhammad Rashid; Hassan, Muhammad Umar; Numan, Ahsan

Iftikhar, Sadaf; Ghias, Mamoona; Shahid, Saman; Ali, Muhammad Rashid; Hassan, Muhammad Umar; Numan, Ahsan.

Affiliation

Iftikhar S; Department of Neurology, King Edward Medical University (KEMU), Mayo Hospital, Lahore, Pakistan.
Ghias M; Department of Medicine, King Edward Medical University (KEMU), Mayo Hospital, Lahore, Pakistan.
Shahid S; Department of Sciences & Humanities, National University of Computer and Emerging Sciences (NUCES), FAST Lahore Campus, Lahore, Pakistan.
Ali MR; Department of Medicine, King Edward Medical University (KEMU), Mayo Hospital, Lahore, Pakistan.
Hassan MU; Department of Neurology, King Edward Medical University (KEMU), Mayo Hospital, Lahore, Pakistan.
Numan A; Department of Neurology, King Edward Medical University (KEMU), Mayo Hospital, Lahore, Pakistan.

Pak J Pharm Sci ; 34(1(Supplementary)): 275-281, 2021 Jan.

Article de En | MEDLINE | ID: mdl-34275851

Sujet(s)

Recherche sur Google

Ajouter à My VHL

Imprimer

XML

PubMed Links

Collection: 01-internacional Base de données: MEDLINE Sujet principal: COVID-19 Type d'étude: Diagnostic_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limites: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Pays/Région comme sujet: Asia Langue: En Journal: Pak J Pharm Sci Sujet du journal: FARMACIA / FARMACOLOGIA / QUIMICA Année: 2021 Type de document: Article Pays d'affiliation: Pakistan

Recherche sur Google

Ajouter à My VHL

Imprimer

XML

PubMed Links